Concepedia

Publication | Open Access

Interim analysis from a phase 2 randomized trial of EuCorVac-19: a recombinant protein SARS-CoV-2 RBD nanoliposome vaccine

DOIFull Paper Access

33

Citations

11

References

2022

Year

Jonathan F. Lovell, Yeong Ok Baik, Seuk Keun Choi, Chankyu Lee, Jeong‐Yoon Lee, Kazutoyo Miura, Wei‐Chiao Huang, Young-Shin Park, Sun‐Je Woo, Sang Hwan Seo,
BMC Medicine

Abstract

The trial was registered at ClinicalTrials.gov as # NCT04783311.

References

YearCitations

Page 1